Inventor · disambiguated record
Giuseppe Bottoni
Also filed as: BOTTONI GIUSEPPE
22 granted patents·12 pending applications·834 citations·filing 1989–2020
96Inventor score
Top patents by PatentIndex Score
34 records- 0194US5472704APharmaceutical controlled-release composition with bioadhesive propertiesRECORDATI CHEM PHARM·Filed 1993·Granted Dec 5, 1995·259 cites·23 claims
- 0292US7157099B2Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compoundsITALFARMACO SPA·Filed 2001·Granted Jan 2, 2007·127 cites·22 claims
- 0391US8217054B2Use of polyols to obtain stable polymorphous forms of rifaximinMAFFEI PAOLA·Filed 2007·Granted Jul 10, 2012·14 cites·30 claims
- 0491US7005421B2Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 2003·Granted Feb 28, 2006·25 cites·58 claims
- 0589US7476689B2Therapeutic compositions for intranasal administration which include KETOROLACRECORDATI IRELAND LTD·Filed 2004·Granted Jan 13, 2009·23 cites·22 claims
- 0687US8748449B2Use of polyols to obtain stable polymorphous forms of rifaximinMAFFEI PAOLA·Filed 2012·Granted Jun 10, 2014·5 cites·36 claims
- 0786US5571533AControlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemideRECORDATI CHEM PHARM·Filed 1994·Granted Nov 5, 1996·111 cites·27 claims
- 0885US6333044B1Therapeutic compositions for intranasal administration which include KETOROLAC®RECORDATI CHEM PHARM·Filed 1995·Granted Dec 25, 2001·53 cites·51 claims
- 0984US6087340AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 1998·Granted Jul 11, 2000·46 cites·23 claims
- 1084US5527545ALiquid-suspension controlled-release pharmaceutical compositionRECORDATI CHEM PHARM·Filed 1993·Granted Jun 18, 1996·66 cites·10 claims
- 1176US5977082AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 1995·Granted Nov 2, 1999·30 cites·23 claims
- 1272US7267827B2Therapeutic compositions for intranasal administration which include KETOROLACRECORDATI CHEM PHARM·Filed 2001·Granted Sep 11, 2007·2 cites·12 claims
- 1371US6632799B2Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 2001·Granted Oct 14, 2003·2 cites·17 claims
- 1469US5670171ALiquid-suspension controlled-release pharmaceutical compositionRECORDATI CHEM PHARM·Filed 1995·Granted Sep 23, 1997·30 cites·3 claims
- 1568US2015072002A1Use of polyols to obtain stable polymorphous forms of rifaxminALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 1667US2005282759A1Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 2004·Application pending·0 cites
- 1765US6984632B1Complexes of paroxetine, with cyclodextrins or cyclodextrin derivativesITALFARMACO SPA·Filed 2000·Granted Jan 10, 2006·2 cites·24 claims
- 1865US2004077560A1Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 2003·Application pending·0 cites
- 1965US2021244714A1Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal diseaseALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 2059US2003013666A1Injectable ready-to-use solutions containing an antitumor anthracycline glycosideFiled 2002·Application pending·0 cites
- 2159US2013183325A1Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulationsALFA WASSERMANN SPA·Filed 2013·Application pending·0 cites
- 2258US6596697B2Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 2001·Granted Jul 22, 2003·0 cites·30 claims
- 2358US2009081133A1Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulationsBOTTONI GIUSEPPE·Filed 2006·Application pending·0 cites
- 2457US10280177B2Use of polyols to obtain stable polymorphous forms of rifaximinALFASIGMA SPA·Filed 2016·Granted May 7, 2019·0 cites·10 claims
- 2557US2015080421A1Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal diseaseALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 2654US2012088726A1Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulationsBOTTONI GIUSEPPE·Filed 2011·Application pending·0 cites
- 2751US2012245192A1Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal diseaseVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Application pending·0 cites
- 2850US4946831AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideERBA FARMITALIA·Filed 1989·Granted Aug 7, 1990·14 cites·6 claims
- 2950US2017071916A1Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal diseaseALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 3047US5124318AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideERBA CARLO SPA·Filed 1990·Granted Jun 23, 1992·12 cites·15 claims
- 3143US6107285AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 1992·Granted Aug 22, 2000·6 cites·13 claims
- 3242US5124317AInjectable ready-to-use solutions containing an antitumor anthracycline glycosideERBA FARMITALIA·Filed 1990·Granted Jun 23, 1992·5 cites·9 claims
- 3338US6284738B1Injectable ready-to-use solutions containing an antitumor anthracycline glycosideUPJOHN CO·Filed 1998·Granted Sep 4, 2001·2 cites·19 claims
- 3433US2012238630A1Compositions comprising nonsteroidal anti - inflammatory drugsVISCOMI GIUSEPPE CLAUDIO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Giuseppe Bottoni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →